Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CLOPIDOGREL BISULFATE Cause Haematuria? 1,146 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 1,146 reports of Haematuria have been filed in association with CLOPIDOGREL BISULFATE (Clopidogrel). This represents 2.5% of all adverse event reports for CLOPIDOGREL BISULFATE.

1,146
Reports of Haematuria with CLOPIDOGREL BISULFATE
2.5%
of all CLOPIDOGREL BISULFATE reports
89
Deaths
904
Hospitalizations

How Dangerous Is Haematuria From CLOPIDOGREL BISULFATE?

Of the 1,146 reports, 89 (7.8%) resulted in death, 904 (78.9%) required hospitalization, and 49 (4.3%) were considered life-threatening.

Is Haematuria Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CLOPIDOGREL BISULFATE. However, 1,146 reports have been filed with the FAERS database.

What Other Side Effects Does CLOPIDOGREL BISULFATE Cause?

Gastrointestinal haemorrhage (5,513) Anaemia (3,043) Dyspnoea (1,963) Drug interaction (1,846) Haemorrhage (1,762) Drug ineffective (1,644) Cerebral haemorrhage (1,603) Dizziness (1,586) Epistaxis (1,560) Melaena (1,547)

What Other Drugs Cause Haematuria?

RIVAROXABAN (4,387) ASPIRIN (2,799) APIXABAN (1,401) WARFARIN (970) DABIGATRAN ETEXILATE (702) LANSOPRAZOLE (557) ENOXAPARIN (549) ESOMEPRAZOLE (546) PREDNISONE (492) ADALIMUMAB (479)

Which CLOPIDOGREL BISULFATE Alternatives Have Lower Haematuria Risk?

CLOPIDOGREL BISULFATE vs CLORAZEPATE CLOPIDOGREL BISULFATE vs CLOSTRIDIUM TETANI TOXOID ANTIGEN CLOPIDOGREL BISULFATE vs CLOTHIAPINE CLOPIDOGREL BISULFATE vs CLOTIAZEPAM CLOPIDOGREL BISULFATE vs CLOTRIMAZOLE

Related Pages

CLOPIDOGREL BISULFATE Full Profile All Haematuria Reports All Drugs Causing Haematuria CLOPIDOGREL BISULFATE Demographics